Literature DB >> 4744015

Pharmacokinetics of cefazolin compared with four other cephalosporins.

W M Kirby, C Regamey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4744015     DOI： 10.1093/infdis/128.supplement_2.s341

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  48 in total

1.  Dosage adjustments of cefazolin according to the pharmacokinetics of this new cephalosporin.

Authors:  J Lavillaureix; J M Brogard; M Pinget; F Ledoux
Journal:  Infection       Date:  1975       Impact factor: 3.553

Review 2.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

3.  In vitro and in vivo activity of first generation cephalosporins against Leptospira.

Authors:  Brande M Harris; Peter J Blatz; Mary K Hinkle; Suzanne McCall; Miriam L Beckius; Katrin Mende; Janelle L Robertson; Matthew E Griffith; Clinton K Murray; Duane R Hospenthal
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

Review 4.  Saturable pharmacokinetics in the renal excretion of drugs.

Authors:  C A van Ginneken; F G Russel
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

5.  Protein binding of cefazolin is saturable in vivo both between and within patients.

Authors:  Jane W A Vella-Brincat; Evan J Begg; Carl M J Kirkpatrick; Mei Zhang; Stephen T Chambers; Kate Gallagher
Journal:  Br J Clin Pharmacol       Date:  2007-01-12       Impact factor: 4.335

6.  Double-blind comparison of phlebitis produced by cefazolin versus cephalothin.

Authors:  N K Shemonsky; J C Carrizosa; D Kaye; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

7.  Editorial: Confusion amongst the cephalosporins.

Authors:  R Wise
Journal:  Can Med Assoc J       Date:  1976-07-03       Impact factor: 8.262

8.  Activity of cefazolin against dense populations of enterobacteria.

Authors:  D Greenwood; C H Chan-Teoh; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

9.  Tissue pharmacokinetics of cefazolin in patients with lower limb infections.

Authors:  Amira A Bhalodi; Seth T Housman; Ashley Shepard; James Nugent; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

10.  The pharmacokinetics of cefuroxime after intravenous injection.

Authors:  P E Gower; C H Dash
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.